DE602004022544D1 - Hydrolytische substrate für ein analytabhängiges enzymaktivierungssystem - Google Patents

Hydrolytische substrate für ein analytabhängiges enzymaktivierungssystem

Info

Publication number
DE602004022544D1
DE602004022544D1 DE602004022544T DE602004022544T DE602004022544D1 DE 602004022544 D1 DE602004022544 D1 DE 602004022544D1 DE 602004022544 T DE602004022544 T DE 602004022544T DE 602004022544 T DE602004022544 T DE 602004022544T DE 602004022544 D1 DE602004022544 D1 DE 602004022544D1
Authority
DE
Germany
Prior art keywords
analyte
substrates
hydrolytic
activation system
dependent enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004022544T
Other languages
English (en)
Inventor
Mark Bobrow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PerkinElmer Health Sciences Inc
Original Assignee
PerkinElmer LAS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PerkinElmer LAS Inc filed Critical PerkinElmer LAS Inc
Publication of DE602004022544D1 publication Critical patent/DE602004022544D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/916Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/918Carboxylic ester hydrolases (3.1.1)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/924Hydrolases (3) acting on glycosyl compounds (3.2)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/968High energy substrates, e.g. fluorescent, chemiluminescent, radioactive
DE602004022544T 2003-06-12 2004-06-10 Hydrolytische substrate für ein analytabhängiges enzymaktivierungssystem Active DE602004022544D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32026203P 2003-06-12 2003-06-12
PCT/US2004/018524 WO2004111259A2 (en) 2003-06-12 2004-06-10 Hydrolytic substrates for an analyte-dependent enzyme activation system

Publications (1)

Publication Number Publication Date
DE602004022544D1 true DE602004022544D1 (de) 2009-09-24

Family

ID=33551151

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004022544T Active DE602004022544D1 (de) 2003-06-12 2004-06-10 Hydrolytische substrate für ein analytabhängiges enzymaktivierungssystem

Country Status (5)

Country Link
US (1) US7291474B2 (de)
EP (1) EP1634074B1 (de)
AT (1) ATE439591T1 (de)
DE (1) DE602004022544D1 (de)
WO (1) WO2004111259A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2605014A1 (de) * 2011-12-16 2013-06-19 Merck Patent GmbH Allgemeine Strategie zum Screening von Antikörper-Bibliotheken
MX360107B (es) 2012-11-13 2018-10-23 Adocia Formulación de acción rápida de insulina que comprende un compuesto aniónico sustituido.
WO2015124703A1 (en) 2014-02-24 2015-08-27 Ventana Medical Systems, Inc. Quinone methide analog signal amplification
WO2018075953A1 (en) * 2016-10-20 2018-04-26 Isi Life Sciences, Inc. Detection of urinary tract infections
CN112105743A (zh) 2018-06-08 2020-12-18 乌尔蒂维尤股份有限公司 复用型催化报告分子沉积

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196306A (en) * 1989-03-29 1993-03-23 E. I. Du Pont De Nemours And Company Method for the detection or quantitation of an analyte using an analyte dependent enzyme activation system
US5182203A (en) * 1989-03-29 1993-01-26 E. I. Du Pont De Nemours And Company Bifunctional compounds useful in catalyzed reporter deposition
US5863748A (en) * 1997-03-14 1999-01-26 New Life Science Products, Inc. p-Hydroxycinnamoyl-containing substrates for an analyte dependent enzyme activation system
US6399299B1 (en) * 1998-11-02 2002-06-04 Perkinelmer Life Sciences, Inc. Amplified array analysis system
US6355443B1 (en) * 1999-03-17 2002-03-12 Mark Norman Bobrow 4-(4-hydroxystyryl) pyridine-containing substrates for an analyte dependent enzyme activation system
GB0125532D0 (en) * 2001-10-24 2001-12-12 Burton Michael Enzyme activity indicators

Also Published As

Publication number Publication date
US20070020681A1 (en) 2007-01-25
EP1634074B1 (de) 2009-08-12
WO2004111259A2 (en) 2004-12-23
EP1634074A2 (de) 2006-03-15
EP1634074A4 (de) 2007-08-29
US7291474B2 (en) 2007-11-06
ATE439591T1 (de) 2009-08-15
WO2004111259A3 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
MXPA02004182A (es) Analogos de 8-(anilino)-1-naftalensulfonato y su uso en ensayos de deteccion de analitos.
BRPI0720525B8 (pt) inibidores de mapk/erk quinase
BR0316470A (pt) Derivados de 3-amino-piperadina e métodos de preparação
ATE548375T1 (de) Exemestan und zwischenprodukte davon und verfahren zu dessen herstellung
IS6088A (is) Fjölkirnismyndun með framsæknu ensími
DK1776586T3 (da) Underlag til gennemförelse af funktionelle test af biologiske celler samt fremgangsmåde til coating af et underlag
DE602005013757D1 (de) Enzymsubstrate für fluoreszenzresonanz-energietransfer
ATE236176T1 (de) Neue substrate zur detektion von mikrobiellen metaboliten
WO2008088051A1 (ja) ホスホリルコリン基含有化合物、ホスホリルコリン基含有化合物の製造方法、表面改質剤、及び表面改質剤を用いた表面改質方法
DE602004022544D1 (de) Hydrolytische substrate für ein analytabhängiges enzymaktivierungssystem
MX343745B (es) Nuevos acidos fosfinicos y sus derivados y metodos para su preparacion.
WO2004010842A3 (en) Lipophilic electrophoretic probes
EP1414955A4 (de) Zusammensetzungen zur verbesserung der card(catalyzed reporter deposition)-technik
DE60309862D1 (de) Plattierungsmedien
GB201009941D0 (en) Deubiquitinase assay
FR2916762B1 (fr) Nouveaux substrats enzymatiques de nitroreductase
ATE338798T1 (de) Chemielumineszierende reaktionen unter verwendung von dihydroxylierten aromaten und heterocyclischen enolphosphaten
BR0015163A (pt) Substrato enzimático, processo de sìntese de um substrato enzimático, composição e processo para a detecção e/ou a identificação e/ou a quantificação de pelo menos um microorganismo, kit de diagnóstico e utilização de um substrato enzimático
WO2004094658A3 (en) Fluorescent substrates for detecting organophosphatase enzyme activity
DE60037655D1 (de) 4-(4-hydroxystyryl)pyridin-enthaltende substrate für analytabhängiges enzym aktivierungssystem
CA2323926A1 (en) Novel potentially fluorogenic compounds
WO2005024380A3 (en) Method and system for assaying transferase activity
DE602005011530D1 (de) Verfahren zur Herstellung von Imiquimod und dessen Zwischenverbindungen
AU2003210620A1 (en) Fluorogenic dyes
TW200728873A (en) Liquid crystal sealing agent and method for fabricating liquid crystal panel using the same

Legal Events

Date Code Title Description
8364 No opposition during term of opposition